| Long‐term expanding human airway organoids for disease modeling N Sachs, A Papaspyropoulos, DD Zomer‐van Ommen, I Heo, L Böttinger, ... The EMBO journal 38 (4), e100300, 2019 | 799 | 2019 |
| MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease PA Juge, JS Lee, E Ebstein, H Furukawa, E Dobrinskikh, S Gazal, ... New England Journal of Medicine 379 (23), 2209-2219, 2018 | 398 | 2018 |
| Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohort CHM van Moorsel, MFM van Oosterhout, NP Barlo, PA de Jong, ... American journal of respiratory and critical care medicine 182 (11), 1419-1425, 2010 | 298 | 2010 |
| Methotrexate vs azathioprine in second-line therapy of sarcoidosis ADM Vorselaars, WA Wuyts, VMM Vorselaars, P Zanen, VHM Deneer, ... Chest 144 (3), 805-812, 2013 | 241 | 2013 |
| Predicting outcomes in idiopathic pulmonary fibrosis using automated computed tomographic analysis J Jacob, BJ Bartholmai, S Rajagopalan, CHM Van Moorsel, HW Van Es, ... American journal of respiratory and critical care medicine 198 (6), 767-776, 2018 | 172 | 2018 |
| Systemic cytokine response in patients with community-acquired pneumonia H Endeman, SCA Meijvis, GT Rijkers, H van Velzen–Blad, ... European Respiratory Journal 37 (6), 1431-1438, 2011 | 159 | 2011 |
| Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis NM Korthagen, CHM van Moorsel, NP Barlo, HJT Ruven, A Kruit, M Heron, ... Respiratory medicine 105 (1), 106-113, 2011 | 155 | 2011 |
| Predicting outcomes in rheumatoid arthritis related interstitial lung disease J Jacob, N Hirani, CHM Van Moorsel, S Rajagopalan, JT Murchison, ... European Respiratory Journal 53 (1), 2019 | 139 | 2019 |
| Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis ADM Vorselaars, A Verwoerd, CHM van Moorsel, RGM Keijsers, ... European Respiratory Journal 43 (2), 602-609, 2014 | 134 | 2014 |
| Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis ADM Vorselaars, HA Crommelin, VHM Deneer, B Meek, AME Claessen, ... European Respiratory Journal 46 (1), 175-185, 2015 | 125 | 2015 |
| Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures I Campo, M Luisetti, M Griese, BC Trapnell, F Bonella, J Grutters, ... Orphanet journal of rare diseases 11, 1-10, 2016 | 119 | 2016 |
| Transforming growth factor-β gene polymorphisms in sarcoidosis patients with and without fibrosis A Kruit, JC Grutters, HJT Ruven, CHM van Moorsel, R Weiskirchen, ... Chest 129 (6), 1584-1591, 2006 | 119 | 2006 |
| ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy ADM Vorselaars, CHM Van Moorsel, P Zanen, HJT Ruven, ... Respiratory medicine 109 (2), 279-285, 2015 | 114 | 2015 |
| Short telomere length in IPF lung associates with fibrotic lesions and predicts survival R Snetselaar, AA van Batenburg, MFM van Oosterhout, KM Kazemier, ... PloS one 12 (12), e0189467, 2017 | 110 | 2017 |
| Telomere length in interstitial lung diseases R Snetselaar, CHM Van Moorsel, KM Kazemier, JJ Van Der Vis, P Zanen, ... Chest 148 (4), 1011-1018, 2015 | 108 | 2015 |
| Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis M Veltkamp, PAHM Wijnen, CHM van Moorsel, GT Rijkers, HJT Ruven, ... Clinical & Experimental Immunology 149 (3), 453-462, 2007 | 102 | 2007 |
| Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis NP Barlo, CH van Moorsel, HJ Ruven, P Zanen, JM van den Bosch, ... Sarcoidosis Vasc Diffuse Lung Dis 26 (2), 155-61, 2009 | 96 | 2009 |
| Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis P Spagnolo, H Sato, JC Grutters, EA Renzoni, SE Marshall, HJT Ruven, ... Tissue antigens 70 (3), 219-227, 2007 | 92 | 2007 |
| High-density genetic mapping identifies new susceptibility variants in sarcoidosis phenotypes and shows genomic-driven phenotypic differences NV Rivera, M Ronninger, K Shchetynsky, A Franke, MM Nöthen, ... American journal of respiratory and critical care medicine 193 (9), 1008-1022, 2016 | 91 | 2016 |
| SFTPA2 Mutations in Familial and Sporadic Idiopathic Interstitial Pneumonia CHM van Moorsel, L Ten Klooster, MFM van Oosterhout, PA de Jong, ... American journal of respiratory and critical care medicine 192 (10), 1249-1252, 2015 | 82 | 2015 |
Jan C. GruttersProfessor of Interstitial Lung Diseases在 antoniusziekenhuis.nl 的电子邮件经过验证
